omicron | Page 2 | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Wednesday
July 06, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WEDNESDAY, JULY 06, 2022

omicron

Residents line up at a nucleic acid testing site during a mass testing for the coronavirus disease (COVID-19), at a residential compound in Dalian, Liaoning province, China March 16, 2022. China Daily via REUTERS
Coronavirus chronicle

Nearly 30m under lockdown in China as Covid surges

New Zealand Prime Minister Jacinda Ardern participates in a televised debate with National leader Judith Collins at TVNZ in Auckland, New Zealand, September 22, 2020. Fiona Goodall/Pool via REUTERS/
World+Biz

New Zealand's Ardern signals mandates will ease after Omicron peaks

Photo :Collected
Coronavirus chronicle

Pfizer and BioNTech Omicron-targeted vaccine delayed - BioNTech CEO

(Reuters file image)
USA

US officials prepare for pandemic's next phase as Omicron wanes

 Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store in West Haven, Connecticut, US, February 17, 2021. Photo :Reuters
Coronavirus chronicle

Moderna eyes Covid booster by August, not clear yet if Omicron-specific needed

Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. Photo :Reuters
Coronavirus chronicle

Prior Covid offers less protection vs Omicron; mRNA booster shot efficacy declines within months

People walk in Shibuya shopping area, during a state of emergency amid the coronavirus disease (Covid-19) outbreak in Tokyo, Japan August 29, 2021. Photo :Reuters
World+Biz

Japan's economy rebounds on solid spending, Omicron clouds outlook

Dr Bijon Shil. Sketch: TBS
Interviews

Is Omicron the end of the Covid-19 pandemic?

Illustration: Collected
Covid-19 in Bangladesh

Omicron completely replaced Delta variant in Dhaka last week: icddr,b

A boy wearing a mask to prevent contracting the coronavirus disease (Covid-19) walks on a zebra crossing in Seoul, South Korea, January 25, 2022. Photo :Reuters
Coronavirus chronicle

S Korea turns to self treatment as Omicron fuels soaring Covid-19 cases

Photo :Collected
Coronavirus chronicle

Covid cases surpass 400 mln as Omicron grips world

 A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo :Reuters
Coronavirus chronicle

WHO laments 'tragic' 500,000 Covid death toll since Omicron

New Zealand Prime Minister Jacinda Ardern participates in a televised debate with National leader Judith Collins at TVNZ in Auckland, New Zealand, September 22, 2020. Fiona Goodall/Pool via REUTERS/
Coronavirus chronicle

New Zealand PM warns of more Covid-19 variants in 2022

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
A customer checks a knife at a blacksmith’s shop at the capital’s Karwan Bazar. Knives and other Qurbani tools are in huge demand as the country prepares to celebrate Eid-Ul-Azha. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net